Fimlab Revenue and Competitors
Estimated Revenue & Valuation
- Fimlab's estimated annual revenue is currently $75.4M per year.
- Fimlab's estimated revenue per employee is $297,000
Employee Data
- Fimlab has 254 Employees.
- Fimlab grew their employee count by 0% last year.
Fimlab's People
Name | Title | Email/Phone |
---|---|---|
1 | Regional Director | Reveal Email/Phone |
2 | Director, Projects | Reveal Email/Phone |
3 | Regional Director | Reveal Email/Phone |
4 | IT Project Manager | Reveal Email/Phone |
5 | Service Manager | Reveal Email/Phone |
6 | Biomedical Laboratory Scientist | Reveal Email/Phone |
7 | Biomedical Laboratory Scientist | Reveal Email/Phone |
8 | System Specialist | Reveal Email/Phone |
9 | System Support Specialist | Reveal Email/Phone |
10 | Biomedical Laboratory Scientist | Reveal Email/Phone |
Fimlab Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $75.4M | 254 | 0% | N/A | N/A |
#2 | $30M | 111 | -1% | N/A | N/A |
#3 | $4M | 21 | 0% | N/A | N/A |
#4 | $9.9M | 46 | -19% | N/A | N/A |
#5 | $31.3M | 116 | 18% | N/A | N/A |
#6 | $21.9M | 81 | 84% | N/A | N/A |
What Is Fimlab?
Fimlab Laboratories (Fimlab Laboratoriot Oy) is one of the leading laboratory companies in Finland. Fimlab provides laboratory services, education and research in Pirkanmaa, Central Finland and Tavastia regions.
keywords:N/AN/A
Total Funding
254
Number of Employees
$75.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fimlab News
2022-03-30 - Hoitajien lakko peruu vastaanottoaikoja ja vaikuttaa myös ...
Coxa on henkilökohtaisesti yhteydessä potilaisiinsa, joiden hoitoon lakko aiheuttaa muutoksia. Laboratorioyhtiö Fimlab ei ole lakon piirissä.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $44.5M | 279 | 34% | N/A |
#2 | $47.2M | 296 | 6% | N/A |
#3 | $125.9M | 351 | 7% | N/A |
#4 | $86.6M | 396 | 6% | N/A |
#5 | $82.2M | 411 | 29% | N/A |